Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 14
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase III Adjuvant Immunotherapy and Radiotherapy for Resectable Squamous, Adeno or Large Cell Lung Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
no age specified
NCI
SWOG-7718
2.
Surgery and Adjuvant Immunotherapy with BCG and Levamisole for Completely Resected non-Small Cell Cancer of the Lung
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
WA-LUN-1
NOG-2177
Last Modified:
5/16/2006
3.
Phase III Adjuvant BCG/INH/LEV Immunotherapy vs CAP-I (CTX/ADR/CACP) for Stage II/III Large Cell and Adenocarcinoma of the Lung
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
no age specified
LCSG-772
4.
Phase III Comparative Studies of Immunotherapy with BCG and INH, Chemotherapy with MTX, Radiotherapy, and Surgery for Disseminated Cancer of the Head and Neck
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
MI-HN-1
5.
Phase III Immunotherapy with BCG for Stage I/II/III Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
MI-LUN-1
6.
Phase III Immunotherapy with BCG for Stage I Resected non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NY-LUN-1
NCI-C76-164
Last Modified:
7/20/2007
7.
Phase III Intradermal BCG plus Nontumorigenic Autologous Cancer Cells for Resected Stage II/III Lung and Esophageal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NCI-C83-0695
C83-0695
Last Modified:
8/14/2007
8.
Phase III Randomized Study of Intravesicular EPI vs BCG vs BCG/INH in Patients with pTa/pT1 Papillary Carcinoma of the Urinary Bladder at Intermediate or High Risk of Recurrence
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Closed
18 to 85
EORTC-30911
Last Modified:
10/1/1997
9.
Phase II Pilot Immunotherapy with Intraperitoneal BCG plus Melphalan/Isoniazid Chemotherapy for Stage IC, II or III Ovarian Adenocarcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
EST-PE-878
10.
Prospective LEV/Radiation vs LEV/BCG/Radiation vs Radiation Alone for Advanced non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Closed
no age specified
NCI-D78-006-225
YALE-1683
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute